Insights into the Mechanisms of Protective Immunity against Cryptococcus neoformans Infection Using a Mouse Model of Pulmonary Cryptococcosis
Open accessAbstract
Cryptococcus neoformans is an opportunistic fungal pathogen that causes life-threatening pneumonia and meningoencephalitis in immune compromised individuals. Previous studies have shown that immunization of BALB/c mice with an IFN-gamma-producing C. neoformans strain, H99gamma, results in complete protection against a second pulmonary challenge with an otherwise lethal cryptococcal strain. The current study evaluated local anamnestic cell-mediated immune responses against pulmonary cryptococcosis in mice immunized with C. neoformans strain H99gamma compared to mice immunized with heat-killed C. neoformans (HKC.n.). Mice immunized with C. neoformans strain H99gamma had significantly reduced pulmonary fungal burden post-secondary challenge compared to mice immunized with HKC.n. Protection against pulmonary cryptococcosis was associated with increased pulmonary granulomatous formation and leukocyte infiltration followed by a rapid resolution of pulmonary inflammation, which protected the lungs from severe allergic bronchopulmonary mycosis (ABPM)-pathology that developed in the lungs of mice immunized with HKC.n. Pulmonary challenge of interleukin (IL)-4 receptor, IL-12p40, IL-12p35, IFN-gamma, T cell and B cell deficient mice with C. neoformans strain H99gamma demonstrated a requirement for Th1-type T cell-mediated immunity, but not B cell-mediated immunity, for the induction of H99gamma-mediated protective immune responses against pulmonary C. neoformans infection. CD4(+) T cells, CD11c(+) cells, and Gr-1(+) cells were increased in both proportion and absolute number in protected mice. In addition, significantly increased production of Th1-type/pro-inflammatory cytokines and chemokines, and conversely, reduced Th2-type cytokine production was observed in the lungs of protected mice. Interestingly, protection was not associated with increased production of cytokines IFN-gamma or TNF-alpha in lungs of protected mice. In conclusion, immunization with C. neoformans strain H99gamma results in the development of protective anti-cryptococcal immune responses that may be measured and subsequently used in the development of immune-based therapies to combat pulmonary cryptococcosis.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Studies in animal models have emphasized the importance of CD4+ T cell-mediated immunity, particularly T helper 1 cells, in protection against cryptococcosis.
“Studies in animal models have emphasized the importance of CD4+ T cell-mediated immunity (particularly T helper 1 cells) in protection against cryptococcosis120,121.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [120]
This immune response is mediated by production of cytokines including IL-2, IL-12, TNF and IFNγ, which recruit phagocytes that help to clear the infection.
“This immune response is mediated by the production of cytokines, including interleukin-2 (IL-2), IL-12, tumour necrosis factor (TNF) and interferon-γ (IFNγ), which in turn recruit phagocytes that help to clear the infection120,122.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [120]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
Mitchell, T. G., & Perfect, J. R. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.515 · Cited by 1,213 · see citing works
Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice
Daley, J. M., Thomay, A. A., Connolly, M. D., Reichner, J. S., & Albina, J. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0407247 · Cited by 1,047 · see citing works
The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection
Davis, J. M., & Ramakrishnan, L. (2009) · Cell · doi:10.1016/j.cell.2008.11.014 · Cited by 907 · see citing works
Infections withCryptococcus neoformansin the Acquired Immunodeficiency Syndrome
Chuck, S. L., & Sande, M. A. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909213211205 · Cited by 801 · see citing works
Nakano, H., Yanagita, M., & Gunn, M. D. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.8.1171 · Cited by 715 · see citing works
Urease as a Virulence Factor in Experimental Cryptococcosis
Cox, G. M., Mukherjee, J., Cole, G. T., Casadevall, A., & Perfect, J. R. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.443-448.2000 · Cited by 522 · see citing works
The Ecology of Cryptococcus neoformans and the Epidemiology of Cryptococcosis
Levitz, S. M. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.6.1163 · Cited by 425 · see citing works
The immune response to fungal infections
Shoham, S., & Levitz, S. M. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05397.x · Cited by 392 · see citing works
Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans
Cox, G. M., McDade, H. C., Chen, W., Tucker, S. C., Gottfreðsson, M., Wright, L. C., Sorrell, T. C., Leidich, S. D., Casadevall, A., Ghannoum, M. A., et al. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02236.x · Cited by 362 · see citing works
Dendritic Cell Responses to Early Murine Cytomegalovirus Infection
Dalod, M., Hamilton, T., Salomon, R., Salazar‐Mather, T. P., Henry, S. C., Hamilton, J. D., & Biron, C. A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021522 · Cited by 357 · see citing works
Decken, K., Köhler, G., Palmer-Lehmann, K., Wunderlin, A., Mattner, F., Magram, J., Gately, M. K., & Alber, G. (1998) · Infection and Immunity · doi:10.1128/iai.66.10.4994-5000.1998 · Cited by 311 · see citing works
Antibody immunity and invasive fungal infections
Casadevall, A. (1995) · Infection and Immunity · doi:10.1128/iai.63.11.4211-4218.1995 · Cited by 282 · see citing works
Müller, U., Stenzel, W., Köhler, G., Werner, C., Polte, T., Hansen, G., Schütze, N., Straubinger, R. K., Blessing, M., McKenzie, A. N. J., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5367 · Cited by 272 · see citing works
Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells.
Huffnagle, G. B., Yates, J. L., & Lipscomb, M. F. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.4.793 · Cited by 265 · see citing works
Dromer, F., Charreire, J., Contrepois, A., Carbon, C., & Yeni, P. (1987) · Infection and Immunity · doi:10.1128/iai.55.3.749-752.1987 · Cited by 243 · see citing works
Singh, N., Dromer, F., Perfect, J. R., & Lortholary, O. (2008) · Clinical Infectious Diseases · doi:10.1086/592690 · Cited by 220 · see citing works
Huffnagle, G. B., Toews, G. B., Burdick, M., Boyd, M. B., McAllister, K. S., McDonald, R. A., Kunkel, S. L., & Strieter, R. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.10.4529 · Cited by 215 · see citing works
Huffnagle, G. B., Lipscomb, M. F., Lovchik, J. A., Hoag, K. A., & Street, N. E. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.55.1.35 · Cited by 206 · see citing works
Recombinant Interferon‐γ1b as Adjunctive Therapy for AIDS‐Related Acute Cryptococcal Meningitis
Pappas, P. G., Bustamante, B., Ticona, E., Hamill, R. J., Johnson, P. C., Reboli, A., Aberg, J., Hasbun, R., & Hsu, H. H. (2004) · The Journal of Infectious Diseases · doi:10.1086/420829 · Cited by 202 · see citing works
Kawakami, K., Qureshi, M. H., Zhang, T., Okamura, H., Kurimoto, M., & Saitô, A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.11.5528 · Cited by 193 · see citing works
Wormley, F. L., Perfect, J. R., Steele, C., & Cox, G. M. (2007) · Infection and Immunity · doi:10.1128/iai.00274-06 · Cited by 187 · see citing works
Self-citationSantangelo, R., Zoellner, H., Sorrell, T., Wilson, C., Donald, C., Djordjevic, J., Shounan, Y., & Wright, L. (2004) · Infection and Immunity · doi:10.1128/iai.72.4.2229-2239.2004 · Cited by 169 · see citing works
Mody, C. H., Lipscomb, M. F., Street, N. E., & Toews, G. B. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.4.1472 · Cited by 164 · see citing works
Allendoerfer, R., & Deepe, G. S. (1998) · PubMed · Cited by 164 · see citing works
A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis
Mordue, D. G., & Sibley, L. D. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403164 · Cited by 163 · see citing works
Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans
Luberto, C., Martinez-Mariño, B., Taraskiewicz, D., Bolaños, B., Chitano, P., Toffaletti, D. L., Cox, G. M., Perfect, J. R., Hannun, Y. A., Balish, E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18309 · Cited by 156 · see citing works
Allendoerfer, R., & Deepe, G. S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.6072 · Cited by 156 · see citing works
Voelz, K., Lammas, D. A., & May, R. C. (2009) · Infection and Immunity · doi:10.1128/iai.00297-09 · Cited by 153 · see citing works
IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans
Kawakami, K., Tohyama, M., Xie, Q.-M., & Saitô, A. (1996) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1996.14723.x · Cited by 150 · see citing works
Levitz, S. M., Nong, S.-H., Mansour, M. K., Huang, C., & Specht, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181331398 · Cited by 146 · see citing works
Arora, S., Hernández, Y., Erb‐Downward, J. R., McDonald, R. A., Toews, G. B., & Huffnagle, G. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6346 · Cited by 144 · see citing works
Huffnagle, G. B., Yates, J. L., & Lipscomb, M. F. (1991) · Infection and Immunity · doi:10.1128/iai.59.4.1423-1433.1991 · Cited by 141 · see citing works
Herring, A. C., Lee, J., McDonald, R. A., Toews, G. B., & Huffnagle, G. B. (2002) · Infection and Immunity · doi:10.1128/iai.70.6.2959-2964.2002 · Cited by 140 · see citing works
CRYPTOCOCCAL INFECTION AND TH1-TH2 CYTOKINE BALANCE
Koguchi, Y., & Kawakami, K. (2002) · International Reviews of Immunology · doi:10.1080/08830180213274 · Cited by 138 · see citing works
Clemons, K. V., Brummer, E., & Stevens, D. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.460 · Cited by 134 · see citing works
Hill, J. O., & Harmsen, A. G. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.3.755 · Cited by 132 · see citing works
Yauch, L. E., Lam, J. S., & Levitz, S. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020120 · Cited by 130 · see citing works
Mednick, A. J., Feldmesser, M., Rivera, J., & Casadevall, A. (2003) · European Journal of Immunology · doi:10.1002/eji.200323626 · Cited by 128 · see citing works
Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.
Mukherjee, J., Pirofski, L., Scharff, M. D., & Casadevall, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3636 · Cited by 116 · see citing works
Kawakami, K., Tohyama, M., Qifeng, X., et al. (1997) · Infection and Immunity · doi:10.1128/iai.65.4.1307-1312.1997 · Cited by 116 · see citing works
Antibody-mediated protection against intracellular pathogens
Casadevall, A. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01208-6 · Cited by 116 · see citing works
Osterholzer, J. J., Curtis, J. L., Polak, T., Ames, T. M., Chen, G.-H., McDonald, R. A., Huffnagle, G. B., & Toews, G. B. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.610 · Cited by 115 · see citing works
Zhou, P., Miller, G., & Seder, R. A. (1998) · PubMed · Cited by 110 · see citing works
Zhou, P., Miller, G., & Seder, R. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1359 · Cited by 102 · see citing works
Huang, C., Nong, S.-H., Mansour, M. K., Specht, C. A., & Levitz, S. M. (2002) · Infection and Immunity · doi:10.1128/iai.70.10.5485-5493.2002 · Cited by 100 · see citing works
Kawakami, K., Tohyama, M., Teruya, K., Kudeken, N., Xie, Q., & Saitô, A. (1996) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1996.tb00225.x · Cited by 90 · see citing works
Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus
Singh, N., Gayowski, T., Wagener, M. M., et al. (1997) · Clinical Transplantation · doi:10.1111/j.1399-0012.1997.tb00783.x · Cited by 90 · see citing works
Evolution of the Primary Immune Response toHistoplasma capsulatumin Murine Lung
Cain, J. A., & Deepe, G. S. (1998) · Infection and Immunity · doi:10.1128/iai.66.4.1473-1481.1998 · Cited by 88 · see citing works
Chen, G.-H., McNamara, D. A., Hernández, Y., Huffnagle, G. B., Toews, G. B., & Olszewski, M. A. (2008) · Infection and Immunity · doi:10.1128/iai.01143-07 · Cited by 87 · see citing works
Self-citationKawakami, K., Qifeng, X., Tohyama, M., et al. (1996) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-870.x · Cited by 83 · see citing works
Chen, G.-H., Olszewski, M. A., McDonald, R. A., Wells, J. C., Paine, R., Huffnagle, G. B., & Toews, G. B. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060595 · Cited by 82 · see citing works
Self-citationInsights into Mechanisms of Antibody-Mediated Immunity from Studies with Cryptococcus neoformans
Casadevall, A., & Pirofski, L. (2005) · Current Molecular Medicine · doi:10.2174/1566524054022567 · Cited by 78 · see citing works
Bauman, S. K., Huffnagle, G. B., & Murphy, J. W. (2002) · Infection and Immunity · doi:10.1128/iai.71.1.68-74.2003 · Cited by 74 · see citing works
Blackstock, R., Buchanan, K. L., Adesina, A. M., & Murphy, J. W. (1999) · Infection and Immunity · doi:10.1128/iai.67.7.3601-3609.1999 · Cited by 73 · see citing works
Buchanan, K. L., & Doyle, H. A. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.456-462.2000 · Cited by 72 · see citing works
Cells and cytokines in pulmonary cryptococcosis
Huffnagle, G. B., & Lipscomb, M. F. (1998) · Research in Immunology · doi:10.1016/s0923-2494(98)80762-1 · Cited by 70 · see citing works
Singh, N., Gayowski, T., Wagener, M. M., et al. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.179 · Cited by 70 · see citing works
Herring, A. C., Falkowski, N. R., Chen, G.-H., McDonald, R. A., Toews, G. B., & Huffnagle, G. B. (2004) · Infection and Immunity · doi:10.1128/iai.73.1.39-49.2005 · Cited by 69 · see citing works
Wüthrich, M., Filutowicz, H. I., Warner, T., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6969 · Cited by 64 · see citing works
Enhancement of antifungal chemotherapy by interferon-gamma in experimental systemic cryptococcosis
Lutz, J. E. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.3.437 · Cited by 60 · see citing works
Murphy, J. W., Schafer, F. B., Casadevall, A., & Adesina, A. M. (1998) · Infection and Immunity · doi:10.1128/iai.66.6.2632-2639.1998 · Cited by 59 · see citing works
Joly, V., Saint-Julien, L., Carbon, C., & Yéni, P. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.5.1331 · Cited by 58 · see citing works
Zhou, Q., Gault, R. A., Kozel, T. R., & Murphy, W. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5753 · Cited by 54 · see citing works
Identification and Cloning of a Cryptococcal Deacetylase That Produces Protective Immune Responses
Biondo, C., Beninati, C., Delfino, D., Oggioni, M. R., Mancuso, G., Midiri, A., Bombaci, M., Tomaselli, G., & Teti, G. (2002) · Infection and Immunity · doi:10.1128/iai.70.5.2383-2391.2002 · Cited by 52 · see citing works
Deepe, G. S., & Gibbons, R. S. (2005) · The Journal of Infectious Diseases · doi:10.1086/498981 · Cited by 43 · see citing works
A proteomic‐based approach for the identification of immunodominant Cryptococcus neoformans proteins
Young, M. L., Macias, S., Thomas, D. P., & Wormley, F. L. (2009) · PROTEOMICS · doi:10.1002/pmic.200800713 · Cited by 41 · see citing works
Self-citationGranulocyte colony stimulating factor therapy of experimental cryptococcal meningitis
Graybill, J. R., Bocanegra, R., Lambros, C., & Luther, M. F. (1997) · Medical Mycology · doi:10.1080/02681219780001221 · Cited by 38 · see citing works
Mandel, M. A., Grace, G. G., Orsborn, K. I., Schafer, F. B., Murphy, J. W., Orbach, M. J., & Galgiani, J. N. (2000) · Infection and Immunity · doi:10.1128/iai.68.11.6196-6201.2000 · Cited by 30 · see citing works
Blasi, E., Mazzolla, R., Barluzzi, R., Mosci, P., & Bistoni, F. (1994) · Infection and Immunity · doi:10.1128/iai.62.8.3189-3196.1994 · Cited by 19 · see citing works
Infection with Histoplasma capsulatum: Host-fungus interface.
Allendoerfer, R., & Deepe, G. S. (1998) · PubMed · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Treatment strategies for cryptococcal infection: challenges, advances and future outlook
Iyer, K. R., Revie, N. M., Fu, C., Robbins, N., & Cowen, L. E. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00511-0 · Cited by 363 · see citing works
A neglected epidemic: Fungal infections in HIV/AIDS
Armstrong-James, D., Meintjes, G., & Brown, G. D. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.01.001 · Cited by 325 · see citing works
Trojan Horse Transit Contributes to Blood-Brain Barrier Crossing of a Eukaryotic Pathogen
Santiago-Tirado, F. H., Onken, M. D., Cooper, J. A., Klein, R. S., & Doering, T. L. (2017) · mBio · doi:10.1128/mbio.02183-16 · Cited by 238 · see citing works
Jarvis, J. N., Meintjes, G., Bicanic, T., Buffa, V., Hogan, L., Mo, S., Tomlinson, G., Kropf, P., Noursadeghi, M., & Harrison, T. S. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004754 · Cited by 150 · see citing works
Protective Immunity against Experimental Pulmonary Cryptococcosis in T Cell-Depleted Mice
Wozniak, K. L., Young, M. L., & Wormley, F. L. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00036-11 · Cited by 72 · see citing works
Self-citationA Call to Arms: Quest for a Cryptococcal Vaccine
Caballero Van Dyke, M. C., & Wormley, F. L. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2017.10.002 · Cited by 61 · see citing works
Self-citation
- Authors
- Wozniak, K. L., Ravi, S., Macias, S., Young, M. L., Olszewski, M. A., Steele, C., & Wormley, F. L.
- Affiliations
- The University of Texas at San Antonio (US)
- VA Ann Arbor Healthcare System (US)
- University of Alabama at Birmingham (US)
- Corresponding author
- Wormley, Floyd L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-09-03
- Volume
- 4
- Issue
- 9
- Pages
- e6854
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2731172
- OpenAlex
- W2076677132
- Cited by
- 99
- References
- 70
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 7 · 2021: 8 · 2020: 5 · 2019: 6 · 2018: 11 · 2017: 6 · 2016: 8 · 2015: 4 · 2014: 8 · 2013: 6 · 2012: 6
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL080317, HL080317)
- National Institute of Allergy and Infectious Diseases (R01AI071752, RO1AI071752)
- Topics
- Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- Cryptococcus neoformans, pulmonary cryptococcosis, protective immunity, Th1 response, granulomatous inflammation, allergic bronchopulmonary mycosis, cytokine and chemokine production, Th2 cytokines, CD4+ T cells, CD11c+ cells, Gr-1+ cells, meningoencephalitis
- MeSH terms
- Animals, Antibodies, Fungal, Cryptococcosis, Cryptococcus neoformans, Disease Models, Animal, Female, Immunity, Cellular, Leukocytes, Lung, Lung Diseases, Fungal, Mice, Inbred BALB C, T-Lymphocytes, Cytokines, Th1 Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review